A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
暂无分享，去创建一个
G. Abou-Alfa | J. Harding | M. Lowery | M. Capanu | J. Bomalaski | D. Kelsen | Kenneth H. Yu | E. O’Reilly | A. Johnston | E. Hollywood | Xiaoxing Feng | D. Glassman | Christina M. Covington | R. Brenner | A. Barba | K. Liu